Compared to its American brethren, Altria Group, which had an 8.6% cigarette volume decline last quarter, Philip Morris ...

The U.S. Food and Drug Administration’s recent approval of a product known as Zyn is a leap forward for the cause of tobacco ...

Why did Swedish nicotine pouches become a generation's go-to fix for blasting through long work days and longer nights out?

What stock should an investor buy for diversification ... It has the leading heat-not-burn device, IQOS, and owns Zyn, the dominant nicotine pouch brand in the United States.

Here's why the stock is a great buy as the company tackles the ... It has the leading heat-not-burn device, IQOS, and owns Zyn, the dominant nicotine pouch brand in the United States.

Shares of Altria (NYSE: MO), the tobacco giant best known as the domestic maker of Marlboro cigarettes, were heading lower ...

Altria (NYSE:MO) is set to report fourth quarter earnings on Thursday, and investors will focus on the tobacco giant’s ...

The bull market rallied into 2025, but is a bear market coming? Learn about 5 defensive stocks that could benefit if a bear ...

LAHORE: The US Food and Drug Administration (FDA) has authorized ZYN nicotine pouches making ZYN the first and only authorized nicotine pouch in the United States. The FDA’s authorization of all ...

The FDA’s recent approval of ZYN nicotine pouches marks a significant development in the realm of tobacco harm reduction. This decision underscores the agency’s commitment to public health benefits ...